Financhill
Buy
60

HON Quote, Financials, Valuation and Earnings

Last price:
$226.78
Seasonality move :
5.35%
Day range:
$224.62 - $229.75
52-week range:
$189.66 - $242.77
Dividend yield:
1.91%
P/E ratio:
26.36x
P/S ratio:
3.96x
P/B ratio:
8.53x
Volume:
6.8M
Avg. volume:
4.6M
1-year change:
12.53%
Market cap:
$148.5B
Revenue:
$36.7B
EPS (TTM):
$8.66
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $36.7B $32.6B $34.4B $35.5B $36.7B
Revenue Growth (YoY) -12.18% -11.09% 5.38% 3.12% 3.37%
 
Cost of Revenues $24.3B $22.2B $22.1B $22.3B $23B
Gross Profit $12.4B $10.5B $12.3B $13.1B $13.7B
Gross Profit Margin 33.7% 32.07% 35.85% 36.99% 37.28%
 
R&D Expenses -- -- $1.3B $1.5B $1.5B
Selling, General & Admin $5.5B $4.8B $4.8B $5.2B $5.1B
Other Inc / (Exp) $810M $568M $1.3B $228M $519M
Operating Expenses $5.5B $4.8B $6.1B $6.7B $6.6B
Operating Income $6.9B $5.7B $6.2B $6.4B $7.1B
 
Net Interest Expenses $102M $252M $241M $276M $444M
EBT. Incl. Unusual Items $7.6B $6B $7.2B $6.4B $7.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.3B $1.1B $1.6B $1.4B $1.5B
Net Income to Company $6.2B $4.9B $5.6B $5B $5.7B
 
Minority Interest in Earnings -$87M -$86M -$68M -$1M -$14M
Net Income to Common Excl Extra Items $6.1B $4.8B $5.5B $5B $5.7B
 
Basic EPS (Cont. Ops) $8.52 $6.79 $8.01 $7.33 $8.53
Diluted EPS (Cont. Ops) $8.41 $6.72 $7.91 $7.27 $8.47
Weighted Average Basic Share $721M $704.1M $692.3M $677.1M $663M
Weighted Average Diluted Share $730.3M $711.2M $700.4M $683.1M $668.2M
 
EBITDA $9B $7.4B $8.8B $8B $9.1B
EBIT $7.9B $6.4B $7.6B $6.8B $7.9B
 
Revenue (Reported) $36.7B $32.6B $34.4B $35.5B $36.7B
Operating Income (Reported) $6.9B $5.7B $6.2B $6.4B $7.1B
Operating Income (Adjusted) $7.9B $6.4B $7.6B $6.8B $7.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $7.8B $8.5B $9B $9.2B $9.7B
Revenue Growth (YoY) -14.19% 8.67% 5.64% 2.92% 5.6%
 
Cost of Revenues $5.4B $5.7B $5.6B $5.7B $6B
Gross Profit $2.4B $2.7B $3.4B $3.5B $3.7B
Gross Profit Margin 30.96% 32.19% 37.5% 38.45% 38.54%
 
R&D Expenses -- -- $387M $364M $368M
Selling, General & Admin $1.1B $1.2B $1.2B $1.3B $1.4B
Other Inc / (Exp) -$82M $187M $300M $158M $28M
Operating Expenses $1.1B $1.2B $1.6B $1.6B $1.8B
Operating Income $1.3B $1.6B $1.7B $1.9B $2B
 
Net Interest Expenses $81M $62M $61M $117M $187M
EBT. Incl. Unusual Items $1.1B $1.7B $2B $2B $1.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $367M $427M $432M $452M $409M
Net Income to Company $781M $1.3B $1.5B $1.5B $1.4B
 
Minority Interest in Earnings -$23M -$16M $3M -$1M -$2M
Net Income to Common Excl Extra Items $758M $1.3B $1.6B $1.5B $1.4B
 
Basic EPS (Cont. Ops) $1.08 $1.82 $2.30 $2.29 $2.17
Diluted EPS (Cont. Ops) $1.07 $1.80 $2.28 $2.27 $2.16
Weighted Average Basic Share $702.6M $690.6M $674.1M $662.4M $650.4M
Weighted Average Diluted Share $709.6M $698.9M $679.6M $667M $654.1M
 
EBITDA $1.5B $2.1B $2.4B $2.5B $2.5B
EBIT $1.2B $1.8B $2.1B $2.2B $2.1B
 
Revenue (Reported) $7.8B $8.5B $9B $9.2B $9.7B
Operating Income (Reported) $1.3B $1.6B $1.7B $1.9B $2B
Operating Income (Adjusted) $1.2B $1.8B $2.1B $2.2B $2.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $33.2B $34.6B $34.9B $36.4B $37.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $22.5B $23.4B $21.2B $22.6B $23.6B
Gross Profit $10.7B $11.2B $13.8B $13.8B $14.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $1.5B $1.5B
Selling, General & Admin $5B $4.8B $5.2B $5.1B $5.4B
Other Inc / (Exp) $563M $1.1B $1.1B -$67M $335M
Operating Expenses $5B $4.8B $7.6B $6.5B $6.8B
Operating Income $5.7B $6.4B $6.1B $7.3B $7.4B
 
Net Interest Expenses $208M $267M $241M $405M $564M
EBT. Incl. Unusual Items $6.1B $7.2B $7B $6.8B $7.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $994M $1.6B $1.6B $1.4B $1.5B
Net Income to Company $5.1B $5.5B $5.4B $5.4B $5.7B
 
Minority Interest in Earnings -$94M -$74M -$13M -$31M -$15M
Net Income to Common Excl Extra Items $5B $5.5B $5.4B $5.4B $5.7B
 
Basic EPS (Cont. Ops) $7.04 $7.87 $7.89 $8.14 $8.70
Diluted EPS (Cont. Ops) $6.97 $7.78 $7.81 $8.07 $8.66
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $7.4B $8.7B $8.5B $8.7B $9.4B
EBIT $6.4B $7.5B $7.3B $7.5B $8.1B
 
Revenue (Reported) $33.2B $34.6B $34.9B $36.4B $37.9B
Operating Income (Reported) $5.7B $6.4B $6.1B $7.3B $7.4B
Operating Income (Adjusted) $6.4B $7.5B $7.3B $7.5B $8.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $23.7B $25.7B $26.3B $27.2B $28.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $16.2B $17.5B $16.6B $16.8B $17.4B
Gross Profit $7.5B $8.3B $9.7B $10.4B $11B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $1.1B $1.1B $1.1B
Selling, General & Admin $3.5B $3.6B $4B $3.8B $4.1B
Other Inc / (Exp) $460M $953M $769M $474M $290M
Operating Expenses $3.5B $3.6B $5.1B $4.9B $5.2B
Operating Income $4B $4.7B $4.6B $5.5B $5.8B
 
Net Interest Expenses $178M $193M $193M $322M $442M
EBT. Incl. Unusual Items $4.3B $5.4B $5.2B $5.7B $5.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $816M $1.3B $1.2B $1.2B $1.2B
Net Income to Company $3.5B $4.2B $3.9B $4.4B $4.5B
 
Minority Interest in Earnings -$66M -$54M $1M -$29M -$30M
Net Income to Common Excl Extra Items $3.4B $4.1B $3.9B $4.4B $4.4B
 
Basic EPS (Cont. Ops) $4.85 $5.93 $5.82 $6.62 $6.78
Diluted EPS (Cont. Ops) $4.81 $5.87 $5.76 $6.56 $6.75
Weighted Average Basic Share $2.1B $2.1B $2B $2B $2B
Weighted Average Diluted Share $2.1B $2.1B $2.1B $2B $2B
 
EBITDA $5.3B $6.6B $6.4B $7.1B $7.4B
EBIT $4.6B $5.7B $5.5B $6.2B $6.4B
 
Revenue (Reported) $23.7B $25.7B $26.3B $27.2B $28.4B
Operating Income (Reported) $4B $4.7B $4.6B $5.5B $5.8B
Operating Income (Adjusted) $4.6B $5.7B $5.5B $6.2B $6.4B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $9.1B $14.3B $11B $9.6B $7.9B
Short Term Investments $1.3B $945M $564M $483M $170M
Accounts Receivable, Net $7.5B $6.8B $6.8B $7.4B $7.5B
Inventory $4.4B $4.5B $5.1B $5.5B $6.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2B $1.6B $1.9B $1.9B $1.7B
Total Current Assets $24.3B $28.2B $25.4B $25B $23.5B
 
Property Plant And Equipment $5.3B $5.6B $5.6B $5.5B $5.7B
Long-Term Investments $588M $685M $1.2B $945M $939M
Goodwill $15.6B $16.1B $17.8B $17.5B $18B
Other Intangibles $3.7B $3.6B $3.6B $3.2B $3.2B
Other Long-Term Assets $8.7B $9.4B $10.1B $9.5B $9.6B
Total Assets $58.7B $64.6B $64.5B $62.3B $61.5B
 
Accounts Payable $5.7B $5.8B $6.5B $6.3B $6.8B
Accrued Expenses $2.6B $2.2B $2.2B $3.3B $1.7B
Current Portion Of Long-Term Debt $4.9B $6B $5.3B $4.4B $3.9B
Current Portion Of Capital Lease Obligations $171M $187M $185M $192M $196M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $18.1B $19.2B $19.5B $19.9B $18.5B
 
Long-Term Debt $11.1B $16.3B $14.3B $15.1B $16.6B
Capital Leases -- -- -- -- --
Total Liabilities $40B $46.8B $45.2B $44.9B $45.1B
 
Common Stock $958M $958M $958M $958M $958M
Other Common Equity Adj -$3.2B -$3.4B -$2.9B -$3.5B -$4.1B
Common Equity $18.5B $17.5B $18.6B $16.7B $15.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $219M $248M $680M $629M $585M
Total Equity $18.7B $17.8B $19.2B $17.3B $16.4B
 
Total Liabilities and Equity $58.7B $64.6B $64.5B $62.3B $61.5B
Cash and Short Terms $10.4B $15.2B $11.5B $10.1B $8.1B
Total Debt $16B $22.4B $19.6B $19.6B $20.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $14B $11.1B $7.4B $7.8B $10.6B
Short Term Investments $972M $1B $516M $164M $275M
Accounts Receivable, Net $6.9B $7.2B $7.4B $7.8B $7.9B
Inventory $4.7B $5B $5.5B $6B $6.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.6B $1.7B $1.7B $1.6B $1.5B
Total Current Assets $28.2B $26B $22.5B $23.3B $28.2B
 
Property Plant And Equipment $5.4B $5.5B $5.3B $5.5B $5.8B
Long-Term Investments $673M $1.2B $807M $895M $1.5B
Goodwill $15.7B $17B $17B $17.8B $21.3B
Other Intangibles $3.5B $3.6B $3.2B $3.3B $5.7B
Other Long-Term Assets $9.5B $9.7B $10.7B $9.9B $10.5B
Total Assets $63.5B $64.2B $60.3B $61.3B $73.5B
 
Accounts Payable $5.3B $6.1B $6.1B $6.4B $6.6B
Accrued Expenses $7.4B $7.2B $7.2B $7.2B $7.6B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- $433M
Total Current Liabilities $17.2B $20.2B $18.1B $17.2B $19.5B
 
Long-Term Debt $17.7B $14.3B $12.2B $16.7B $25.9B
Capital Leases -- -- -- -- --
Total Liabilities $45.1B $46.1B $42B $43.5B $55.5B
 
Common Stock $958M $958M $958M $958M $958M
Other Common Equity Adj $102M -$3.2B -$3.3B -$3.6B -$4.4B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $246M $279M $630M $551M $575M
Total Equity $18.3B $18.1B $18.3B $17.8B $18B
 
Total Liabilities and Equity $63.5B $64.2B $60.3B $61.3B $73.5B
Cash and Short Terms $15B $12.1B $8B $7.9B $10.9B
Total Debt $22.2B $21.2B $17B $20.3B $30.8B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $6.2B $4.9B $5.6B $5B $5.7B
Depreciation & Amoritzation $1.1B $1B $1.2B $1.2B $1.2B
Stock-Based Compensation $153M $168M $217M $188M $202M
Change in Accounts Receivable $11M $669M -$8M -$739M -$42M
Change in Inventories -$100M -$67M -$685M -$440M -$626M
Cash From Operations $6.9B $6.2B $6B $5.3B $5.3B
 
Capital Expenditures $839M $906M $895M $766M $1B
Cash Acquisitions -$50M -$261M -$1.1B -$178M -$714M
Cash From Investing -$533M -$987M -$1.1B -$93M -$1.3B
 
Dividends Paid (Ex Special Dividend) -$2.4B -$2.6B -$2.6B -$2.7B -$2.9B
Special Dividend Paid
Long-Term Debt Issued $16.9B $20.6B $7.7B $10.6B $16B
Long-Term Debt Repaid -$17.1B -$14.7B -$10.1B -$10.3B -$15.4B
Repurchase of Common Stock -$4.4B -$3.7B -$3.4B -$4.2B -$3.7B
Other Financing Activities -$79M -$59M -$81M -$48M $28M
Cash From Financing -$6.6B -$81M -$8.3B -$6.3B -$5.8B
 
Beginning Cash (CF) $9.3B $9.1B $14.3B $11B $9.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$236M $5.1B -$3.3B -$1.1B -$1.7B
Ending Cash (CF) $9.1B $14.3B $11B $9.6B $7.9B
 
Levered Free Cash Flow $6.1B $5.3B $5.1B $4.5B $4.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $781M $1.3B $1.5B $1.5B $1.4B
Depreciation & Amoritzation $255M $308M $300M $308M $357M
Stock-Based Compensation $40M $56M $50M $39M $45M
Change in Accounts Receivable -$161M -$292M $244M $161M -$69M
Change in Inventories $47M -$245M $44M -$110M -$156M
Cash From Operations $1B $1.1B $2.1B $1.8B $2B
 
Capital Expenditures $249M $208M $184M $249M $279M
Cash Acquisitions -- $6M -- -$55M -$2.1B
Cash From Investing -$52M -$104M $126M -$45M -$2.8B
 
Dividends Paid (Ex Special Dividend) -$636M -$646M -$669M -$728M -$715M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.4B $3.8B $2.4B $2.7B $7.2B
Long-Term Debt Repaid -$4.4B -$3.8B -$4.1B -$3.6B -$4.8B
Repurchase of Common Stock -$164M -$650M -$390M -$1B --
Other Financing Activities -$14M -$41M -$24M -$27M -$21M
Cash From Financing -$769M -$1.3B -$2.8B -$2.6B $1.8B
 
Beginning Cash (CF) $13.8B $11.4B $8.2B $8.6B $9.6B
Foreign Exchange Rate Adjustment $72M -$37M -$231M -$56M $108M
Additions / Reductions $186M -$303M -$568M -$800M $960M
Ending Cash (CF) $14B $11.1B $7.4B $7.8B $10.6B
 
Levered Free Cash Flow $758M $911M $1.9B $1.6B $1.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $5.1B $5.5B $5.4B $5.4B $5.7B
Depreciation & Amoritzation $1B $1.2B $1.2B $1.2B $1.3B
Stock-Based Compensation $159M $222M $208M $173M $207M
Change in Accounts Receivable $704M -$365M -$249M -$423M $84M
Change in Inventories -$108M -$299M -$559M -$498M -$411M
Cash From Operations $6B $6.2B $5.6B $4.8B $6.8B
 
Capital Expenditures $950M $905M $806M $916M $1.1B
Cash Acquisitions -- -$1.4B -$170M -$716M -$7B
Cash From Investing -$821M -$1.9B $826M -$1.4B -$8.7B
 
Dividends Paid (Ex Special Dividend) -$2.6B -$2.6B -$2.7B -$2.8B -$2.9B
Special Dividend Paid
Long-Term Debt Issued $22.6B $8.1B $6.9B $19B $22.2B
Long-Term Debt Repaid -$19.4B -$9B -$10.3B -$16B -$12.4B
Repurchase of Common Stock -$2.9B -$4.1B -$3.7B -$3.6B -$2.7B
Other Financing Activities -$61M -$79M -$52M -$68M $98M
Cash From Financing -$2.1B -$7.2B -$9.7B -$3.1B $4.7B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.1B -$3B -$3.3B $216M $2.8B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $5.1B $5.3B $4.8B $3.8B $5.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $3.5B $4.2B $3.9B $4.4B $4.5B
Depreciation & Amoritzation $748M $933M $905M $875M $957M
Stock-Based Compensation $118M $172M $163M $148M $153M
Change in Accounts Receivable $615M -$419M -$660M -$344M -$218M
Change in Inventories -$284M -$516M -$390M -$448M -$233M
Cash From Operations $3.4B $3.4B $2.9B $2.4B $3.8B
 
Capital Expenditures $615M $614M $525M $675M $771M
Cash Acquisitions -- -$1.1B -$178M -$716M -$7B
Cash From Investing -$410M -$1.3B $540M -$754M -$8.2B
 
Dividends Paid (Ex Special Dividend) -$1.9B -$2B -$2B -$2.1B -$2.2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $18.7B $6.1B $5.3B $13.7B $19.9B
Long-Term Debt Repaid -$12.7B -$7B -$7.1B -$12.9B -$9.9B
Repurchase of Common Stock -$2.1B -$2.5B -$2.8B -$2.2B -$1.2B
Other Financing Activities -$54M -$74M -$45M -$65M $5M
Cash From Financing $2B -$5.2B -$6.6B -$3.4B $7.1B
 
Beginning Cash (CF) $30.6B $37.4B $28.5B $25.1B $29.3B
Foreign Exchange Rate Adjustment -$19M -$21M -$349M -$61M $47M
Additions / Reductions $5B -$3.2B -$3.2B -$1.8B $2.7B
Ending Cash (CF) $35.5B $34.2B $25B $23.3B $32B
 
Levered Free Cash Flow $2.8B $2.8B $2.4B $1.7B $3B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 1.36% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.63% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.53% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock